{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T05:07:43Z","timestamp":1772255263638,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.htct.2021.06.007","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T23:20:56Z","timestamp":1629933656000},"page":"497-503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Overall survival in Chilean patients with lymphoma and human immunodeficiency virus: A retrospective cohort study"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5322-2374","authenticated-orcid":false,"given":"Rafael","family":"Benavente","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8076-2077","authenticated-orcid":false,"given":"Camila","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2824-9409","authenticated-orcid":false,"given":"Andr\u00e9s","family":"Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0381-9196","authenticated-orcid":false,"given":"Ximena","family":"Valladares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3942-6987","authenticated-orcid":false,"given":"B\u00e1rbara","family":"Puga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9059-3871","authenticated-orcid":false,"given":"Mar\u00eda Elena","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2021.06.007_bib0001","unstructured":"Joint United Nations Programme for HIV\/AIDS. UNAIDS Data 2019 [cited 2021 April 20th]. Available from: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2019-UNAIDS-data_en.pdf"},{"key":"10.1016\/j.htct.2021.06.007_bib0002","series-title":"Resultados confirmaci\u00f3n de infecci\u00f3n por VIH","year":"2010"},{"issue":"3","key":"10.1016\/j.htct.2021.06.007_bib0003","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/QAI.0b013e3181eb4fb9","article-title":"Chilean AIDS Cohort Study Group. Long-term outcomes of a national expanded access program to antiretroviral therapy: the Chilean AIDS Cohort","volume":"55","author":"Wolff","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"10.1016\/j.htct.2021.06.007_bib0004","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jnci\/djr076","article-title":"Cancer burden in the HIV-infected population in the United States","volume":"103","author":"Shiels","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.htct.2021.06.007_bib0005","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2019.004","article-title":"HIV and lymphoma: from epidemiology to clinical management","volume":"11","author":"Re","year":"2019","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"6","key":"10.1016\/j.htct.2021.06.007_bib0006","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2008.19.6626","article-title":"Highly active antiretroviral therapy and the incidence of non-AIDS- defining cancers in people with HIV infection","volume":"27","author":"Powles","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.htct.2021.06.007_bib0007","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/cncr.21562","article-title":"Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival","volume":"106","author":"Diamond","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.htct.2021.06.007_bib0008","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1086\/379517","article-title":"Improvement of systemic human immunodeficiency virus-related non-Hodgkin lymphoma outcome in the era of highly active antiretroviral therapy","volume":"37","author":"Vaccher","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.htct.2021.06.007_bib0009","first-page":"117","article-title":"Lymphomas and HIV infection in a reference hospital of Santiago, Chile: 1990-2002: report of 14 cases and review","volume":"24","author":"Osorio","year":"2007","journal-title":"Rev Chil Infect"},{"issue":"1","key":"10.1016\/j.htct.2021.06.007_bib0010","first-page":"27","article-title":"Lymphomas associated with human immunodeficiency virus infection: retrospective review of medical records","volume":"139","author":"Rojas","year":"2011","journal-title":"Rev Med Chile"},{"issue":"12","key":"10.1016\/j.htct.2021.06.007_bib0011","first-page":"1505","article-title":"Intensive chemotherapy for Burkitt lymphoma in HIV positive patients","volume":"143","author":"Puga","year":"2015","journal-title":"Rev Med Chile"},{"key":"10.1016\/j.htct.2021.06.007_bib0012","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4067\/S0034-98872012000200015","article-title":"HIV-related lymphoma in a public hospital in Chile. Analysis of 55 cases","volume":"140","author":"Cabrera","year":"2012","journal-title":"Rev Med Chile"},{"key":"10.1016\/j.htct.2021.06.007_bib0013","series-title":"Protocolos c\u00e1ncer del adulto 2013-2014","first-page":"564","year":"2014"},{"key":"10.1016\/j.htct.2021.06.007_bib0014","series-title":"WHO classification of tumors of hematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.htct.2021.06.007_bib0015","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A prognostic score for advanced Hodgkin's disease. International prognostic factors project on advanced Hodgkin's disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.htct.2021.06.007_bib0016","first-page":"987","article-title":"The International non-Hodgkin's lymphoma prognostic factors project","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.htct.2021.06.007_bib0017","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJM198204013061303","article-title":"Alternating drug combinations in the treatment of advanced Hodgkin's disease","volume":"306","author":"Santoro","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.htct.2021.06.007_bib0018","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood-2005-04-1437","article-title":"Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010","volume":"106","author":"Kaplan","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.htct.2021.06.007_bib0019","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1182\/blood-2003-06-2094","article-title":"Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL","volume":"104","author":"Pfreundschuh","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.htct.2021.06.007_bib0020","series-title":"Gu\u00eda Cl\u00ednica AUGE \u201cSindrome de la Inmunodeficiencia adquirida VIH\/SIDA\u201d","year":"2013"},{"issue":"14","key":"10.1016\/j.htct.2021.06.007_bib0021","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1182\/blood-2011-08-373738","article-title":"How I treat HIV-associated lymphoma","volume":"119","author":"Dunleavy","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.htct.2021.06.007_bib0022","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1365-2141.2011.08771.x","article-title":"Diagnosis of Burkitt lymphoma using an algorithmic approach\u2013applicable in both resource-poor and resource-rich countries","volume":"154","author":"Naresh","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.htct.2021.06.007_bib0023","doi-asserted-by":"crossref","first-page":"e16129","DOI":"10.1097\/MD.0000000000016129","article-title":"HIV-related lymphomas in adults served in the public health network: an observational study","volume":"98","author":"da Silva Nascimento","year":"2019","journal-title":"Medicine"},{"issue":"19","key":"10.1016\/j.htct.2021.06.007_bib0024","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1182\/blood-2013-04-498964","article-title":"Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients","volume":"122","author":"Barta","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.htct.2021.06.007_bib0025","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/CCO.0b013e3283094ec7","article-title":"Management of AIDS-related lymphoma","volume":"20","author":"Levine","year":"2008","journal-title":"Curr Opin Oncol"},{"issue":"7","key":"10.1016\/j.htct.2021.06.007_bib0026","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/QAD.0000000000000624","article-title":"HIV infection impact on clinical-biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era","volume":"29","author":"Baptista","year":"2015","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.htct.2021.06.007_bib0027","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3109\/10428194.2013.813499","article-title":"Molecular characteristics of diffuse large B-cell lymphoma in human immunodeficiency virus-infected and -uninfected patients in the pre-highly active antiretroviral therapy and pre-rituximab era","volume":"55","author":"Morton","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"10.1016\/j.htct.2021.06.007_bib0028","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.3109\/10428194.2013.878933","article-title":"Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma\/leukemia: parallel study of 81 patients","volume":"55","author":"Xicoy","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"10.1016\/j.htct.2021.06.007_bib0029","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/cid\/civ627","article-title":"High risk features contrast with favorable outcomes in HIV-associated hodgkin lymphoma in the modern cART era, ANRS CO16 LYMPHOVIR cohort","volume":"61","author":"Besson","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"21","key":"10.1016\/j.htct.2021.06.007_bib0030","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1002\/cncr.27551","article-title":"Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy","volume":"118","author":"Castillo","year":"2012","journal-title":"Cancer"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137921001012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137921001012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:35:02Z","timestamp":1762868102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137921001012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2531137921001012"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2021.06.007","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overall survival in Chilean patients with lymphoma and human immunodeficiency virus: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2021.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}